Vanderbilt Heart and Vascular Institute (VHVI) Archive — Page 3 of 9

Members of Vanderbilt Heart and Vascular Institute (VHVI) gathered for a photo last week to recognize National Wear Red Day — an observance created by the American Heart Association and the National Heart, Lung and Blood Institute to raise awareness of heart disease, which is the leading cause of death in the United States.
February 10, 2022

Wear Red Day

Members of Vanderbilt Heart and Vascular Institute (VHVI) gathered for a photo last week to recognize National Wear Red Day — an observance created by the American Heart Association and the National Heart, Lung and Blood Institute to raise awareness of heart disease, which is the leading cause of death in the United States.

By Vanderbilt Health News
October 21, 2021

VUMC lauded for hypertrophic cardiomyopathy care

Vanderbilt University Medical Center was recently named a center of excellence for hypertrophic cardiomyopathy by the Hypertrophic Cardiomyopathy Association.

By Matt Batcheldor
September 15, 2021

VHVI reaches milestone in cardiac monitor implants

Vanderbilt has reached a new milestone in implanting CardioMEMS remote cardiac monitoring devices.

By Matt Batcheldor
September 9, 2021

VHVI offers latest therapies to treat atrial fibrillation

Vanderbilt Heart and Vascular Institute continues to offer the latest in therapies to treat atrial fibrillation (AF or AFib), the most common cardiac arrhythmia.

By Matt Batcheldor
After receiving his LVAD, patient Brandon Cochran was able to leave the hospital and spend more time with his wife, Amy, and daughters Olivia and Stella.
September 2, 2021

Novel LVAD allows patient to see family, celebrate milestones

Brandon Cochran, a 39-year-old real estate agent in Louisville, Kentucky, was at home with his family in October 2020 when he went into cardiac arrest. His implanted defibrillator shocked him back to life, and he was hospitalized for seven months.

By Matt Batcheldor
The Structural Heart and Valve Center team has recently completed multiple groundbreaking transcatheter clinical trial procedures treating severe regurgitation of the mitral and tricuspid valves.
August 12, 2021

Structural Heart and Valve Center reaches procedure milestones

The Structural Heart and Valve Center at Vanderbilt Heart and Vascular Institute (VHVI) has recently completed multiple groundbreaking transcatheter clinical trial procedures treating severe regurgitation of the mitral and tricuspid valves, a continuation of a decade of research that is revolutionizing the treatment of these conditions.

By Matt Batcheldor